Fund moves
74 tracked managers disclosed the same change for Q4 2025. From a 13F filed Jan 5, 2026 covering holdings at Dec 31, 2025 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Dec 8, 2025 · Filed Dec 8, 2025
The CEO of Linde paid $1M out of pocket for Linde shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$999,634
Shares × reported transaction price
$500K–$1M
+2.9%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
This purchase equals about 4.8% of the CEO's reported total pay for fiscal 2024 ($20.7M)
Purchase value ÷ the CEO's total from the Summary Compensation Table, as tagged in the pay versus performance table of the company's proxy statement (DEF 14A), filed 2026-04-29. The proxy names Sanjiv Lamba as CEO for that year. A size comparison, not a judgement
38 days after results of Oct 31, 2025, 59 days before results of Feb 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $389.38 on Dec 8, 2025, at its 52-week low, after a 13% drop over the previous 30 trading days
52-week range $389.38 (Dec 8, 2025) to $483.59 (Sep 11, 2025), 0% of the way up, from 250 adjusted closes. 30 trading days earlier: $446.00 on Oct 24, 2025. Describes the past only, not a forecast
RSI 22, 15% under its 200-day average, 10% under its 50-day average, 19% below the 52-week high, 20-day volatility 15% a year, against the S&P 500: −8 points over 1 month, −23 points over 3 months, −32 points over 6 months
From the adjusted closes up to Dec 8, 2025. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Sanjiv Lamba's first purchase of LIN since Mar 2022
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +8.5% | −0.6% | +9.1% |
| 30 days | +12.6% | +0.9% | +11.7% |
| 90 days | +23.9% | −0.7% | +24.6% |
| 180 days | +28.6% | +8.2% | +20.4% |
Past results only. Not a forecast.
Fund moves
74 tracked managers disclosed the same change for Q4 2025. From a 13F filed Jan 5, 2026 covering holdings at Dec 31, 2025 — a quarter-end snapshot, not a live trade.
Fund moves
76 tracked managers disclosed the same change for Q3 2025. From a 13F filed Nov 17, 2025 covering holdings at Sep 30, 2025 — a quarter-end snapshot, not a live trade.
Fund moves
76 tracked managers disclosed the same change for Q3 2025. From a 13F filed Nov 14, 2025 covering holdings at Sep 30, 2025 — a quarter-end snapshot, not a live trade.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.